February 7, 2017 - February 8, 2017
The Great Hall, Humphrey Building
200 Independence Avenue, S.W.
Washington, DC 20201
Agenda
Day 1 – Tuesday, February 7th
Time | Agenda Item | Presenter(s) |
---|---|---|
9:20 – 10:00 a.m. | Welcome | |
9:20 a.m. | Welcome by the Principal Deputy Assistant Secretary for Health and Outgoing Member Appreciation | Dr. Bruce Gellin, Director, NVPO Dr. Jewel Mullen, Acting Assistant Secretary for Health |
9:50 a.m. | Chair’s Updates | Dr. Kim Thompson, NVAC Chair |
10:00 – 11:30 a.m. | NVAC at 30 | |
10:00 a.m. | Remarks from NVPO | Dr. Bruce Gellin, Director, NVPO |
10:05 a.m. | National Vaccine Program and National Vaccine Advisory Committee: Beginnings and Highlights | Dr. Alan Hinman, Senior Advisor, Center for Vaccine Equity, Task Force for Global Health |
10:35 a.m. | NVAC and the Future of Vaccinology | Dr. Stanley Plotkin, Emeritus Professor, University of Pennsylvania |
11:05 a.m. | Discussion | |
11:30 – 11:45 a.m. | Break | |
11:45 – 1:00 p.m. | Vaccine Safety Science and Personalized Vaccinology | |
11:45 a.m. | The Case for Personalized Vaccinology in the 21st Century | Dr. Gregory Poland, Mary Lowell Leary Emeritus Professor of Medicine, Distinguished Mayo Investigator, Director, Mayo Vaccine Research Group, Mayo Clinic |
12:05 p.m. | Metabolites as Biomarkers of Adverse Reactions Following Vaccination: A Pilot Study using Nuclear Magnetic Resonance Metabolomics | Dr. Bruce McClenathan, Regional Medical Director, Defense Health Agency, DoD |
12:25 p.m. | (Almost) All Immunity is Local—Implications for Vaccines from Tissue Immunodynamics | Dr. Chuck Hackett, Deputy Director of the Division of Allergy, Immunology, and Transplantation, NIAID |
12:45 p.m. | Discussion | |
1:00 – 2:00 p.m. | Lunch | |
2:00 – 2:45 p.m. | Vaccine Delivery Systems | |
2:00 p.m. | Innovative Vaccine Delivery Technologies: New Paradigms for Immuno-protective Countermeasures | Dr. Jonathan Seals, Director, Strategic Science and Technology, BARDA |
2:30 p.m. | Discussion | |
2:45 – 3:45 p.m. | NVAC MCR Working Group (WG): Findings, Recommendations, and Voting | |
2:45 p.m. | Summary Presentation | Dr. Yvonne Maldonado, NVAC Dr. Nate Smith, NVAC |
3:15 p.m. | Discussion | |
3:30 p.m. | Public Comment | |
3:40 p.m. | Vote | |
3:45 – 4:00 p.m. | Break | |
4:00 – 5:00 p.m. | Updates on Mumps Outbreaks | |
4:00 p.m. | Mumps Epidemiology and Public Health Response in Minnesota | Dr. Ruth Lynfield, NVAC |
4:20 p.m. | Update on Mumps Outbreaks: Arkansas | Dr. Nate Smith, NVAC |
4:40 p.m. | Update on Mumps Outbreaks: CDC | Dr. Nancy Messonnier, CDC |
4:50 p.m. | Discussion | |
5:00pm– 5:15pm | Public Comment | |
5:15 p.m. | Adjourn |
Day 2 – Wednesday, February 8th
Time | Agenda Item | Presenter(s) |
---|---|---|
9:00 – 9:05 a.m. | Welcome and Wrap-up from Previous Day | Dr. Kim Thompson, NVAC Chair |
9:05 – 10:00 a.m. | Zika Vaccine Development | |
9:05 a.m. | Zika Virus Epidemiology Update | Dr. Marc Fischer, Medical Epidemiologist, DVBD, NCEZID, CDC |
9:25 a.m. | Overview: Zika Vaccines in Development | Dr. Gerald Kovacs, Senior Advisor, BARDA, ASPR |
9:45 a.m. | Discussion | |
10:00 – 10:30 a.m. | Vaccines in the 21 Century Cures Act | |
10:00 a.m. | Vaccine Innovation | Dr. Bruce Gellin, Director, NVPO |
10:05 a.m. | Impact on VICP | Dr. Narayan Nair, HRSA |
10:10 a.m. | Impact on CDC | Dr. Nancy Messonnier, CDC |
10:15 a.m. | Additional Comments from NIH and FDA | Dr. Barbara Mulach, NIH Dr. Marion Gruber, FDA |
10:25 a.m. | Discussion | |
10:30 – 10:45am | Break | |
10:45 – 12:15pm | NVAC Liaison and Ex Officio Updates | |
10:45 a.m. | Selected Highlights of Ex-Officios and Liaison Activities | Dr. Rhonda Kropp, PHAC Mr. Troy Knighton, VA Dr. Nancy Messonnier, CDC |
11:15 a.m. | Discussion | |
11:30 a.m. | Liaison Members | ACCV, ACIP, AHIP, AIM, AIRA, ASTHO, NACCHO, PAHO, PHAC, VRBPAC |
11:50 a.m. | Ex Officio Members | AHRQ, ASPR, CDC, CMS, DoD, FDA, HRSA-BPHC, HRSA-DICP, IHS, NIH, USDA, VA |
12:15 – 12:45 p.m. | Childhood Immunizations: Taking the Pulse of the Public | |
12:15 p.m. | Public Views about the MMR Vaccine and Trust in Medical Scientists and their Research on Childhood Vaccines | Dr. Cary Funk, Associate Director, Research on Science and Society Pew Research Center |
12:35 p.m. | Discussion | |
12:45 – 1:00 p.m. | Public Comment | |
1:00 p.m. | Adjourn |
Abbreviations
ACCV — Advisory Commission on Childhood Vaccines
ACIP — Advisory Committee on Immunization Practices
AHIP — America’s Health Insurance Plans
AHRQ — Agency for Healthcare Research and Quality
AIM — Association of Immunization Managers
AIRA — American Immunization Registry Association
ASPR — Assistant Secretary for Preparedness and Response
ASTHO — Association of State and Territorial Health Officials
BARDA — Biomedical Advanced Research and Development Authority
CDC — Centers for Disease Control and Prevention
CMS — Centers for Medicare and Medicaid Services
DoD — Department of Defense
DVBD — Division of Vector-Borne Diseases
FDA — Food and Drug Administration
HRSA — Health Resources and Services Administration
IHS — Indian Health Services
NACCHO — National Association of County and City Health Officials
NCEZID — National Center for Emerging and Zoonotic Infectious Diseases
NIAID — National Institute of Allergy and Infectious Diseases
NIH — National Institutes of Health
PAHO — Pan American Health Organization
PHAC — Public Health Agency of Canada
USDA — U.S. Department of Agriculture
VA — Department of Veterans Affairs
VRBPAC — Vaccines and Related Biological Products Advisory Committee